摘要: About half of asthmatic patients have eosinophilic asthma; in such patients, rising eosinophilia is associated with worsening asthma control and risk
jwatch.org参考文章(1)
Eugene R Bleecker, J Mark FitzGerald, Pascal Chanez, Alberto Papi, Steven F Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman, Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial The Lancet. ,vol. 388, pp. 2115- 2127 ,(2016) , 10.1016/S0140-6736(16)31324-1